1453-CFTR介导的肝癌免疫微环境重塑与联合治疗研究 episode artwork

EPISODE · Aug 18, 2026 · 20 MIN

1453-CFTR介导的肝癌免疫微环境重塑与联合治疗研究

from 聊聊Sci

这篇研究论文揭示了CFTR(囊性纤维化跨膜电导调节因子)在肝细胞癌(HCC)中的抑癌作用及其免疫调节机制。研究发现,CFTR在肝癌组织中显著低表达,且其表达水平与肿瘤的恶性程度呈负相关。通过激活或过表达CFTR,可以有效降低细胞内氯离子和钙离子浓度,进而抑制RUNX1和NF-κB信号通路,减少促癌细胞因子的分泌。这种机制成功将肿瘤微环境从免疫抑制状态重塑为激活状态,表现为M1型巨噬细胞和CD8+ T细胞浸润增加,同时抑制了调节性T细胞。最终,CFTR的激活与PD-L1抗体展现出显著的协同治疗效应,为提升肝癌免疫治疗疗效提供了新的生物标志物和联合用药方案。References:Xu Y, Sun J, He C, et al. CFTR-driven immune microenvironment reprogramming synergizes with anti-PD-L1 antibody in hepatocellular carcinoma[J]. Cell Death & Disease, 2026.前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Aug 18, 2026

Embed this episode

Ready to play

1453-CFTR介导的肝癌免疫微环境重塑与联合治疗研究

0:00 20:16

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 聊聊Sci?

This episode is 20 minutes long.

When was this 聊聊Sci episode published?

This episode was published on August 18, 2026.

Can I download this 聊聊Sci episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!